There were 2,101 press releases posted in the last 24 hours and 438,080 in the last 365 days.

Global Self Injection Market Analysis 2017-2024 - Becton, Dickinson and Company is Set to Dominate the Market

Dublin, Oct. 18, 2017 (GLOBE NEWSWIRE) -- The "Global Self Injection Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024" report has been added to Research and Markets' offering.

In this report, Global self-injection market is projected to reach USD 52.437.46 million by 2024 from USD 21.950.41 million in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024.

Major factors driving the growth of market are the rising cases of chronic diseases, increasing demand of self-injection devices.

The global self-injection market is segmented on the basis of product type, application, usage pattern, mode of administration, end user, distribution channel and geography:

  • On the basis of product type, market is segmented into 4 types, namely, auto injectors, wearable injectors, needle free injectors (NFI), and pen injectors.
  • On the basis of application, the global self-injection market is segmented into oncology, hormonal disorders, autoimmune diseases, orphan diseases, and others.
  • On the basis of usage pattern the global self-injection market is segmented into curative care, immunization.
  • Based on distribution channel, market is segmented into, Pharmacy stores, hospital pharmacy, direct tender and online pharmacy.
  • Based on mode of administration, the global self-injection market is segmented into circulatory, organs, skin and central nervous system.
  • On the basis of end user, the market is segmented into hospitals, clinics, home care settings, research laboratories and, pharma & biotech companies.

Market Dynamics

Drivers

  • Rising Cases of Chronic Diseases
  • Rising Demand of Self-Injection Devices
  • Growth of Biologics Market
  • Technological Advancements and Innovations in Drug Delivery Market

Restraints

  • High Cost of Development
  • Strict Regulatory Framework

Opportunity

  • Increasing Demand for Generic and Biosimilar Drugs
  • Generics
  • Biosimilars
  • Increasing Demand for Contraceptive Injectables
  • Increasing Demand for Self-Administration of Drugs

Challenges

  • Alternative Route of Drug Administration
  • Product Recall
  • Stability of Products
  • Sterility of Injections

Becton, Dickinson and Company is going to dominate the global self-injection market following with, Novo Nordisk, Sanofi and Pfizer.

Key Topics Covered:

1. Introduction

2. Market Segmentation

3. Market Overview

4. Executive Summary

5. Premium Insights

6. Global Self-Injection Market, Regulatory

7. Global Self-Injection Market, Reimbusement

8. Global Self-Injection Market, by Type

9. Global Self-Injection Market, by Application

10. Global Self-Injection Market, by Usage Pattern

11. Global Self-Injection Market, by Mode of Administration

12. Global Self-Injection Market, by End User

13. Global Self-Injection Market, by Distribution Channel

14. Global Self-Injection Market, by Geography

15. Global Self Injection Market, Company Landscape

16. Company Profiles

  • Elcam Medicalcompany Overview
  • Bespak (Subsidiary of Consort Medical Company)
  • Sanofi
  • Sandoz International Gmbh
  • Sandoz International Gmbh: Revenue Analysis
  • Unilife Corporation
  • West Pharmaceutical Services, Inc
  • Pfizer Inc.
  • Impax Laboratories, Inc.
  • Penjet Corporation
  • Crossject Needle-Free Injection Systems
  • Wilhelm Haselmeier Gmbh & Co. Kg
  • Antares Pharma
  • Becton, Dickinson and Company
  • Gerresheimer Ag
  • Mylan N.V
  • Novo Nordisk
  • Owen Mumford Ltd
  • Pharmajet
  • SHL Group
  • Ypsomed

For more information about this report visit https://www.researchandmarkets.com/research/sd7w57/global_self




CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Infusions and Injectables 

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.